Caroline Kant

Ashoka Fellow
Switzerland
Fellow Since 2014
This description of Caroline Kant's work was prepared when Caroline Kant was elected to the Ashoka Fellowship in 2014.
Introduction
Caroline has created a new way forward for existing drugs to be developed in rare diseases, ultimately bring treatments to these underserved patients at an affordable cost. She is accelerating the cost-effective development of unexplored therapeutic opportunities in rare diseases by addressing key translational gaps and clinical development challenges, acting as an investor, a patient voice integrator and a trusted broker between patients, pharmaceutical companies biomedical centers of expertise and regulatory authorities.
The New Idea
The Problem
The Strategy
The Person

More For You